Combined targeting of the VEGFr/EGFr and the mammalian target of rapamycin (mTOR) signaling pathway delays cell cycle progression and alters adhesion behavior of prostate carcinoma cells
Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, Eva Juengel, Igor Tsaur, Axel Haferkamp, Roman A. BlahetaVolume:
301
Year:
2011
Language:
english
Pages:
29
DOI:
10.1016/j.canlet.2010.11.003
File:
PDF, 526 KB
english, 2011